Knockdown of ANGPTL-4 inhibits inflammatory response and extracellular matrix accumulation in glomerular mesangial cells cultured under high glucose condition

References

• Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes Metab Res Rev. 2017;33:e2841.
   Web of Science ®Google Scholar
• Gross JL, de Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176.
   PubMed Web of Science ®Google Scholar
• Tung CW, Hsu YC, Shih YH, et al. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton). 2018;23:32–37.
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013;124:139–152.
   PubMed Web of Science ®Google Scholar
• Fu J, Lee K, Chuang PY, et al. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am J Physiol Renal Physiol. 2015;308:F287–F297.
   PubMed Web of Science ®Google Scholar
• Maezawa Y, Takemoto M, Yokote K. Cell biology of diabetic nephropathy: roles of endothelial cells, tubulointerstitial cells and podocytes. J Diabetes Invest. 2015;6:3–15.
   PubMed Web of Science ®Google Scholar
• Lu Q, Zou W, Chen B, et al. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2016;254:1281–1288.
   PubMed Web of Science ®Google Scholar
• Lu Q, Lu P, Chen W, et al. ANGPTL-4 induces diabetic retinal inflammation by activating Profilin-1. Exp Eye Res. 2018;166:140–150.
   PubMed Web of Science ®Google Scholar
• Li M, Yang XJ, Zhang GY, et al. ANGPTL4 participates in gestational diabetes mellitus via regulating Akt pathway. Eur Rev Med Pharmacol Sci. 2018;22:5056–5062.
   PubMed Web of Science ®Google Scholar
• Gusarova V, O’Dushlaine C, Teslovich TM, et al. Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes. Nat Commun. 2018;9:2252–2262.
   PubMed Web of Science ®Google Scholar
• La Paglia L, Listi A, Caruso S, et al. Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway. PPAR Res. 2017;2017:8187235–8187249.
   PubMed Web of Science ®Google Scholar
• Xue L, Feng X, Wang C, et al. Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression. BMC Nephrol. 2017;18:307–314.
   PubMed Web of Science ®Google Scholar
• Ma J, Chen X, Li JS, et al. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy. Endocrine. 2015;49:373–384.
   PubMed Web of Science ®Google Scholar
• Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014;5:393–398.
   PubMedGoogle Scholar
• Sifuentes-Franco S, Padilla-Tejeda DE, Carrillo-Ibarra S, et al. Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy. Int J Endocrinol. 2018;2018: 1875870–1875882.
   PubMed Web of Science ®Google Scholar
• Pohlers D, Brenmoehl J, Löffler I, et al. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta. 2009;1792:746–756.
   PubMed Web of Science ®Google Scholar
• Wu P, Wang Y, Davis ME, et al. Store-operated Ca (2+) channels in mesangial cells inhibit matrix protein expression. JASN. 2015;26:2691–2702.
   Web of Science ®Google Scholar
• Chaudhari S, Li W, Wang Y, et al. Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells. Am J Physiol Renal Physiol. 2017;313:F729–F739.
   PubMed Web of Science ®Google Scholar
• Gilmore T. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25:6680–6684.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhu X, Sun Z, et al. Astilbin inhibits high glucose-induced inflammation and extracellular matrix accumulation by suppressing the TLR4/MyD88/NF-kappaB pathway in rat glomerular mesangial cells. Front Pharmacol. 2018;9:1187–1197.
   PubMed Web of Science ®Google Scholar
• Liu Z, Han Y, Zhao F, et al. Nobiletin suppresses high-glucose-induced inflammation and ECM accumulation in human mesangial cells through STAT3/NF-kappaB pathway. J Cell Biochem. 2019;120:3467–3473.
   PubMed Web of Science ®Google Scholar
• Zhu X, Shi J, Li H. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways . Biomed Pharmacother. 2018;106:976–982.
   PubMed Web of Science ®Google Scholar
• Fadia K, Nadezhda YG, Honglan P, et al. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity. Nephron Exp Nephrol. 2010;115:e69–e79.
   PubMedGoogle Scholar
• Guo L, Li S, Zhao Y, et al. Silencing angiopoietin-like protein 4 (ANGPTL4) protects against lipopolysaccharide-induced acute lung injury via regulating SIRT1 /NF-kB pathway. J Cell Physiol. 2015;230:2390–2402.
   PubMed Web of Science ®Google Scholar